---

---

symbols : Azn    crawled time : 09:00   

save search

---

PARP Inhibitors Market to reach over USD 10.31 billion by the year 2031 - Exclusive Report by InsightAce Analytic
Published: 2024-02-21 (Crawled : 09:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 5.3% | O: -0.88% H: 1.75% C: -0.29%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -7.67% | O: 0.8% H: 0.0% C: 0.0%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| -7.26% | O: -0.25% H: 0.0% C: 0.0%
KPTI | $1.265 -8.33% -9.09% 1.3M |

Health Technology

| 14.05% | O: -1.65% H: 3.36% C: 1.68%
CKPT | $1.595 -4.49% -4.7% 470K |

Health Technology

| -14.65% | O: 0.0% H: 1.26% C: -3.03%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 4.96% | O: -1.01% H: 1.1% C: 1.1%
report year reach market

---

Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Advanced Nonsquamous Non-Small Cell Lung Cancer
Published: 2024-02-19 (Crawled : 09:00) - biospace.com/
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| Email alert Add to watchlist
lung license cancer cell application advanced

---

BioInvent to Evaluate BI-1206 in Combination with Rituximab and Calquence
Published: 2024-02-09 (Crawled : 09:00) - biospace.com/
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 7.47% | O: -1.28% H: 1.05% C: -0.72%
bi-1206

---

Hospital Infection Therapeutics Market is to grow by USD 3.10 billion, Special drug designations to boost growth - Technavio
Published: 2024-01-23 (Crawled : 09:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 0.5% | O: -2.34% H: 0.43% C: 0.43%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| -0.72% | O: -2.16% H: 1.17% C: 1.17%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -13.7% | O: 0.46% H: 0.0% C: 0.0%
VTRS | $11.11 0.09% 0.09% 3.5M |

Health Technology

| -4.64% | O: 0.17% H: 1.33% C: 0.94%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -14.19% | O: -0.96% H: 0.3% C: 0.28%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 0.18% | O: -0.76% H: 0.38% C: 0.13%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| -0.14% | O: 0.37% H: 0.0% C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| -6.09% | O: -0.07% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -9.82% | O: -2.05% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 1.68% | O: -1.27% H: 0.8% C: 0.69%
drug hospital infection therapeutics growth market

---

AstraZeneca Awards Funding to Eight Innovative Research Projects From Early-Career Scientists Around the World in Second R&D Postdoctoral Challenge
Published: 2023-10-12 (Crawled : 09:00) - biospace.com/
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 0.37% | O: 0.6% H: 0.34% C: -0.45%
world awards research funding

---

Datopotamab Deruxtecan Demonstrated Statistically Significant and Clinically Meaningful Progression-Free Survival Benefit in Patients with HR Positive, HER2 Low or Negative Breast Cancer in TROPION-Breast01 Phase 3 Trial
Published: 2023-09-22 (Crawled : 09:00) - biospace.com/
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 1.86% | O: 2.01% H: 0.2% C: -0.79%
breast her2 cancer trial negative

---

Large Molecule Injectable Drugs Market to grow by USD 191.45 billion from 2022-2027 | North America to account for 45% of market growth - Technavio
Published: 2023-09-18 (Crawled : 09:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 9.19% | O: 2.7% H: 0.0% C: -5.11%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| -2.15% | O: -2.01% H: 1.73% C: -2.99%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 9.62% | O: -0.05% H: 0.0% C: -1.31%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -9.31% | O: 0.06% H: 0.09% C: -0.6%
MDT | $79.19 0.14% 0.0% 6.1M |

Health Technology

| -3.29% | O: 0.59% H: 1.69% C: 0.67%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 5.8% | O: 0.72% H: 0.13% C: -0.93%
BAX | $39.65 0.33% 0.0% 2.3M |

Health Technology

| 1.59% | O: -0.13% H: 0.28% C: -0.77%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| 7.39% | O: 0.33% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -16.16% | O: -1.29% H: 0.0% C: 0.0%
BIIB | $190.55 -0.84% -0.84% 1.5M |

Health Technology

| -23.41% | O: 0.06% H: 0.44% C: -0.64%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| -0.01% | O: -0.76% H: 0.16% C: -1.65%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 2.38% | O: 1.02% H: 0.7% C: -0.09%
america growth market

---

Nanotechnology Drug Delivery Market to Reach $209.5 Billion, Globally, by 2032 at 9.1% CAGR: Allied Market Research
Published: 2023-07-19 (Crawled : 09:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 0.64% | O: 0.47% H: 1.47% C: 1.47%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 7.82% | O: -1.97% H: 0.0% C: 0.0%
TEVA | $12.78 -3.03% -0.24% 9M |

Health Technology

| 62.12% | O: 1.23% H: 4.13% C: 4.01%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -10.03% | O: 0.61% H: 0.6% C: -0.84%
BMY | $48.3 0.96% -0.1% 11M |

Health Technology

| -22.16% | O: 0.19% H: 1.19% C: -0.1%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 2.24% | O: 1.5% H: 0.75% C: -0.32%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 14.78% | O: 0.18% H: 0.67% C: -0.4%
drug reach research market

---

Lymphoma Therapeutics Market to Reach $35.2 Billion, Globally, by 2032 at 8.4% CAGR: Allied Market Research
Published: 2023-04-27 (Crawled : 09:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560 |

Health Technology

| -8.05% | O: -0.78% H: 0.0% C: 0.0%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -10.98% | O: 0.17% H: 0.31% C: 0.06%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| -7.31% | O: -0.14% H: 0.56% C: 0.31%
reach research therapeutics market

---

Breast cancer therapeutics market size grow by USD 13.85 billion between 2021 to 2026; AbbVie Inc. and Amgen Inc., among others, emerge as key vendors - Technavio
Published: 2023-04-13 (Crawled : 09:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 8.89% | O: 0.54% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -18.15% | O: -1.1% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| -8.11% | O: 0.0% H: 1.63% C: 1.63%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 16.68% | O: 1.25% H: 0.51% C: 0.51%
VTRS | $11.11 0.09% 0.09% 3.5M |

Health Technology

| 13.03% | O: 0.31% H: 1.42% C: 0.71%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -3.51% | O: 1.3% H: 0.56% C: 0.51%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 5.01% | O: 0.85% H: 0.76% C: 0.76%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| 0.96% | O: -0.84% H: 1.16% C: 1.05%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -17.54% | O: 0.29% H: 0.0% C: 0.0%
PBYI | $4.98 -3.68% -3.82% 290K |

Health Technology

| 77.66% | O: -0.34% H: 10.17% C: 6.9%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| -7.45% | O: 0.39% H: 1.05% C: 0.97%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 6.99% | O: -0.36% H: 1.33% C: 1.14%
abbvie breast cancer therapeutics market

---

HUTCHMED Reports 2022 Full Year Results and Provides Business Updates
Published: 2023-02-28 (Crawled : 09:00) - globenewswire.com
AZNCF | $140.15 -4.19% 560 |

Health Technology

| -0.01% | O: -3.3% H: 0.0% C: -1.25%
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| 137.12% | O: -0.36% H: 0.0% C: -1.35%
HCM | $16.38 -0.43% -0.43% 190K |

Health Technology

| 4.71% | O: 5.03% H: 2.91% C: 0.3%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 2.19% | O: -1.65% H: 0.58% C: -0.79%
year results

---

Global Peptide Therapeutics Market to Grow by USD 23.36 Bn, Collaboration for research and development to be the Key Trend - Technavio
Published: 2022-11-02 (Crawled : 09:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 23.28% | O: 3.27% H: 2.19% C: -3.32%
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| 3.92% | O: -2.21% H: 0.0% C: -0.14%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 14.57% | O: 0.8% H: 1.45% C: 0.81%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| 14.83% | O: 0.63% H: 0.61% C: -1.2%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 18.35% | O: 1.91% H: 0.0% C: -2.87%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| 6.74% | O: 0.07% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 14.06% | O: 0.75% H: 1.66% C: -1.0%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| -1.88% | O: -0.15% H: 1.19% C: -0.97%
research global collaboration therapeutics market

---

USD 28.28 Bn growth expected in Vaccines Market -- Driven by increased funding for vaccine development and new vaccine launches
Published: 2022-09-28 (Crawled : 09:00) - prnewswire.com
CMXHF | $172.54 -19.21% 50 |

n/a

| -5.81% | O: -0.61% H: 0.0% C: 0.0%
MTLHY | $29.93 -11.69% 1.1K |

n/a

| 28.15% | O: 1.63% H: 0.0% C: -0.48%
CSLLY | $87.96 3.3% 45K |

n/a

| -3.64% | O: -0.43% H: 1.81% C: 1.44%
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 40.77% | O: 1.05% H: 4.0% C: 4.0%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 27.05% | O: 2.35% H: 0.0% C: -0.68%
ALPMY | $9.46 -1.11% 500K |

Manufacturing

| -28.81% | O: -1.91% H: 2.64% C: 1.94%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 38.17% | O: 1.12% H: 2.14% C: 1.66%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| 23.03% | O: 0.83% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 28.22% | O: 0.04% H: 3.14% C: 2.68%
vaccine expected funding growth market

---

ENHERTU® Significantly Delayed Disease Progression in DESTINY-Breast02 Phase 3 Trial Versus Physician’s Choice of Treatment in Patients with HER2 Positive Metastatic Breast Cancer
Published: 2022-08-15 (Crawled : 09:00) - biospace.com/
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 2.44% | O: 0.92% H: 0.22% C: -0.65%
enhertu treatment disease trial positive cancer her2- her2 metastatic breast cancer

---

HUTCHMED and AstraZeneca Announce that TAGRISSO® Plus Savolitinib Demonstrated 49% Objective Response Rate in Lung Cancer Patients with High Levels of MET Overexpression and/or Amplification in SAVANNAH Phase II Trial
Published: 2022-08-08 (Crawled : 09:00) - chi-med.com
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 5.58% | O: 4.04% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 3.38% | O: -0.53% H: 0.49% C: -0.85%
tagrisso trial response plus cancer

---

Monoclonal Antibodies Market Size to Grow by USD 63.41 Bn, AbbVie Inc., and AstraZeneca Plc Among Key Vendors - Technavio
Published: 2022-07-26 (Crawled : 09:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -6.05% | O: 0.0% H: 0.0% C: -2.33%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 4.84% | O: 3.39% H: 0.42% C: -1.6%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| 8.13% | O: 0.96% H: 0.47% C: -0.08%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -15.98% | O: 0.14% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -6.07% | O: -0.26% H: 1.5% C: 1.12%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| 10.2% | O: 1.61% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -8.57% | O: -0.1% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 3.18% | O: 0.62% H: 1.09% C: 0.23%
market

---

Eli Lilly and Co and Novo Nordisk AS Among Leading Companies in the Type 2 Diabetes Pipeline Market | GlobalData Plc
Published: 2022-07-13 (Crawled : 09:00) - globenewswire.com
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 2.5% | O: -0.51% H: 0.0% C: -1.03%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 2.32% | O: -1.77% H: 1.83% C: 1.16%
companies diabetes market

---

Neuroimmunology Drugs Market worth $37.32 billion by 2030 - Exclusive Report by InsightAce Analytic
Published: 2022-07-06 (Crawled : 09:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 8.52% | O: 9.36% H: 0.0% C: -4.54%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| 11.22% | O: -0.11% H: 0.5% C: 0.16%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -19.02% | O: -0.48% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -7.87% | O: -0.28% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 5.46% | O: 2.15% H: 0.79% C: 0.56%
report market drug

---

Atherosclerosis Therapeutics Market Size to Grow by USD 3.44 billion | Increasing Risk Factors for Atherosclerosis to Boost Growth | Technavio
Published: 2022-04-11 (Crawled : 09:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -13.68% | O: 22.86% H: 0.0% C: -1.09%
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -17.18% | O: 3.07% H: 0.0% C: -0.32%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| -3.98% | O: -2.11% H: 0.0% C: 0.0%
VTRS | $11.11 0.09% 0.09% 3.5M |

Health Technology

| 0.54% | O: -0.36% H: 0.18% C: -2.73%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| 0.38% | O: 1.48% H: 0.17% C: -0.37%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -14.38% | O: 1.51% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -16.75% | O: 4.5% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| -4.04% | O: -0.21% H: 0.41% C: -0.51%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 5.92% | O: 0.63% H: 1.91% C: -1.08%
risk therapeutics growth market

---

Oral Cancer Therapeutics Market - 51% of Growth to Originate from North America | Driven by Increasing Incidence & Prevalence of Oral Cancer| Technavio
Published: 2022-04-05 (Crawled : 09:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -3.12% | O: 7.19% H: 0.0% C: -2.86%
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -13.36% | O: -0.75% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| -0.71% | O: -0.97% H: 0.0% C: -0.99%
VTRS | $11.11 0.09% 0.09% 3.5M |

Health Technology

| 2.3% | O: -0.65% H: 2.32% C: -1.02%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -9.34% | O: 1.3% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -11.24% | O: 0.64% H: 0.0% C: 0.0%
ENDP | $0.2926 -9.6% |

Health Technology

| -87.81% | O: -1.25% H: 3.8% C: -3.8%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 2.39% | O: 0.39% H: 1.79% C: 0.18%
america therapeutics cancer growth market

---

Gainers vs Losers

64%

36%

Top 10 Gainers

AGBA | News | $1.02 155.0% 57.94% 120M |

Finance

ZCMD | $2.86 108.76% 52.1% 2.3M |

Commercial Services

INVO | $1.555 104.6% 51.13% 5M |

Health Technology

ISPC | $0.437 105.16% 49.53% 37M |

Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M |

OST | $0.499 21.38% 45.26% 1.9M |

XPON | News | $3.1 60.62% 37.74% 17M |

TIRX | $0.7 44.39% 30.74% 58M |

BNTC | News | $6.92 44.17% 30.64% 3.5M |

Health Technology

GGE | $0.035 19.86% 29.3% 64M |

---

Your saved searches

---